Skip to main content
Top
Published in: Virology Journal 1/2013

Open Access 01-12-2013 | Research

Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein

Authors: Anita Szalmás, Eszter Gyöngyösi, Annamária Ferenczi, Brigitta László, Tamás Karosi, Péter Csomor, Lajos Gergely, György Veress, József Kónya

Published in: Virology Journal | Issue 1/2013

Login to get access

Abstract

Background

The Src family tyrosine kinases (SFK) are cellular regulatory proteins that influence cell adhesion, proliferation, invasion and survival during tumor development. Elevated activity of Src was associated with increased cell proliferation and invasivity in human papillomavirus (HPV)-associated malignancies; therefore, transduced human foreskin keratinocytes (HFK) were used to investigate whether SFK activation is a downstream effect of papillomaviral oncoproteins. Activation of ubiquitously expressed SFKs, namely Src, Yes and Fyn, was investigated in both proliferating and differentiating keratinocytes.

Results

In proliferating keratinocytes, Src, Yes and Fyn mRNA levels were not affected by HPV 16 E6 or E7 oncoproteins, while at the protein level as detected by western blot, the presence of both E6 and E7 resulted in substantial increase in Src and Yes expression, but did not alter the high constitutive level of Fyn. Phospo-kinase array revealed that all ubiquitously expressed SFKs are activated by phosphorylation in the presence of HPV 16 E7 oncoprotein. Keratinocyte differentiation led to increased Yes mRNA and protein levels in all transduced cell lines, while it did not influence the Src transcription but resulted in elevated Src protein level in HPV16 E7 expressing lines.

Conclusions

This study revealed that HPV 16 oncoproteins upregulate Src family kinases Src and Yes via posttranscriptional mechanisms. A further effect of HPV 16 E7 oncoprotein is to enhance the activating phosphorylation of SFKs expressed in keratinocytes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bradshaw JM: The Src, Syk, and Tec family kinases: Distinct types of molecular switches. Cell Signal 2010, 22: 1175-1184. 10.1016/j.cellsig.2010.03.001PubMedCrossRef Bradshaw JM: The Src, Syk, and Tec family kinases: Distinct types of molecular switches. Cell Signal 2010, 22: 1175-1184. 10.1016/j.cellsig.2010.03.001PubMedCrossRef
2.
go back to reference Cabodi S, Di Stefano P, Leal MDC, Tinnirello A, Bisaro B, Morello V: Integrins and signal transduction. Integrins and Ion Channels: Molecular Complexes and Signaling 2010, 674: 43-54. 10.1007/978-1-4419-6066-5_5CrossRef Cabodi S, Di Stefano P, Leal MDC, Tinnirello A, Bisaro B, Morello V: Integrins and signal transduction. Integrins and Ion Channels: Molecular Complexes and Signaling 2010, 674: 43-54. 10.1007/978-1-4419-6066-5_5CrossRef
3.
go back to reference Kim LC, Song LX, Haura EB: Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 2009, 6: 587-595. 10.1038/nrclinonc.2009.129PubMedCrossRef Kim LC, Song LX, Haura EB: Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 2009, 6: 587-595. 10.1038/nrclinonc.2009.129PubMedCrossRef
4.
go back to reference Roskoski R: Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 2004, 324: 1155-1164. 10.1016/j.bbrc.2004.09.171PubMedCrossRef Roskoski R: Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun 2004, 324: 1155-1164. 10.1016/j.bbrc.2004.09.171PubMedCrossRef
5.
go back to reference Roskoski R: Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 2005, 331: 1-14. 10.1016/j.bbrc.2005.03.012PubMedCrossRef Roskoski R: Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 2005, 331: 1-14. 10.1016/j.bbrc.2005.03.012PubMedCrossRef
6.
go back to reference Guarino M: Src signaling in cancer invasion. J Cell Physiol 2010, 223: 14-26.PubMed Guarino M: Src signaling in cancer invasion. J Cell Physiol 2010, 223: 14-26.PubMed
7.
go back to reference Sen B, Johnson FM: Regulation of SRC family kinases in human cancers. J Signal Transduct 2011,201(1):865819. Sen B, Johnson FM: Regulation of SRC family kinases in human cancers. J Signal Transduct 2011,201(1):865819.
8.
go back to reference Summy JM, Gallick GE: Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 2003, 22: 337-358. 10.1023/A:1023772912750PubMedCrossRef Summy JM, Gallick GE: Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 2003, 22: 337-358. 10.1023/A:1023772912750PubMedCrossRef
9.
go back to reference Hamamura K, Tsuji M, Hotta H, Ohkawa Y, Takahashi M, Shibuya H: Functional activation of Src family kinase Yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3. J Biol Chem 2011, 286: 18526-18537. 10.1074/jbc.M110.164798PubMedPubMedCentralCrossRef Hamamura K, Tsuji M, Hotta H, Ohkawa Y, Takahashi M, Shibuya H: Functional activation of Src family kinase Yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3. J Biol Chem 2011, 286: 18526-18537. 10.1074/jbc.M110.164798PubMedPubMedCentralCrossRef
10.
go back to reference Kluger HM, Dudek AZ, McCann C, Ritacco J, Southard N, Jilaveanu LB: A phase 2 trial of dasatinib in advanced melanoma. Cancer 2011, 117: 2202-2208. 10.1002/cncr.25766PubMedPubMedCentralCrossRef Kluger HM, Dudek AZ, McCann C, Ritacco J, Southard N, Jilaveanu LB: A phase 2 trial of dasatinib in advanced melanoma. Cancer 2011, 117: 2202-2208. 10.1002/cncr.25766PubMedPubMedCentralCrossRef
11.
go back to reference Konecny GE, Glas R, Dering J, Manivong K, Qi J, Finn RS: Activity of the multikinase inhibitor dasatinib against ovarian cancer cells. Br J Cancer 2009, 101: 1699-1708. 10.1038/sj.bjc.6605381PubMedPubMedCentralCrossRef Konecny GE, Glas R, Dering J, Manivong K, Qi J, Finn RS: Activity of the multikinase inhibitor dasatinib against ovarian cancer cells. Br J Cancer 2009, 101: 1699-1708. 10.1038/sj.bjc.6605381PubMedPubMedCentralCrossRef
12.
go back to reference Lee JH, Pyon JK, Kim DW, Lee SH, Nam HS, Kim CH: Elevated c-Src and c-Yes expression in malignant skin cancers. J Exp Clin Cancer Res 2010, 29: 116. 10.1186/1756-9966-29-116PubMedPubMedCentralCrossRef Lee JH, Pyon JK, Kim DW, Lee SH, Nam HS, Kim CH: Elevated c-Src and c-Yes expression in malignant skin cancers. J Exp Clin Cancer Res 2010, 29: 116. 10.1186/1756-9966-29-116PubMedPubMedCentralCrossRef
13.
go back to reference Montero JC, Seoane S, Ocana A, Pandiella A: Inhibition of Src family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors. Clin Cancer Res 2011, 17: 5546-5552. 10.1158/1078-0432.CCR-10-2616PubMedCrossRef Montero JC, Seoane S, Ocana A, Pandiella A: Inhibition of Src family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors. Clin Cancer Res 2011, 17: 5546-5552. 10.1158/1078-0432.CCR-10-2616PubMedCrossRef
15.
go back to reference Tamm C, Galito SP, Anneren C: Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors. Exp Cell Res 2012, 318: 336-349. 10.1016/j.yexcr.2011.12.008PubMedCrossRef Tamm C, Galito SP, Anneren C: Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors. Exp Cell Res 2012, 318: 336-349. 10.1016/j.yexcr.2011.12.008PubMedCrossRef
16.
go back to reference Kong L, Deng ZH, Zhao YZ, Wang YM, Sarkar FH, Zhang YX: Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells. Med Oncol 2011, 28: 1495-1506. 10.1007/s12032-010-9583-3PubMedCrossRef Kong L, Deng ZH, Zhao YZ, Wang YM, Sarkar FH, Zhang YX: Down-regulation of phospho-non-receptor Src tyrosine kinases contributes to growth inhibition of cervical cancer cells. Med Oncol 2011, 28: 1495-1506. 10.1007/s12032-010-9583-3PubMedCrossRef
17.
go back to reference Kong L, Deng ZH, Shen HY, Zhang YX: Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173. Mol Cell Biochem 2011, 348: 11-19. 10.1007/s11010-010-0632-1PubMedCrossRef Kong L, Deng ZH, Shen HY, Zhang YX: Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173. Mol Cell Biochem 2011, 348: 11-19. 10.1007/s11010-010-0632-1PubMedCrossRef
18.
go back to reference Yasmeen A, Alachkar A, Dekhil H, Gambacorti-Passerini C, Al Moustafa AE: Locking Src/Abl Tyrosine Kinase Activities Regulate Cell Differentiation and Invasion of Human Cervical Cancer Cells Expressing E6/E7 Oncoproteins of High-Risk HPV. J Oncol 2010,2010(530130):10. Yasmeen A, Alachkar A, Dekhil H, Gambacorti-Passerini C, Al Moustafa AE: Locking Src/Abl Tyrosine Kinase Activities Regulate Cell Differentiation and Invasion of Human Cervical Cancer Cells Expressing E6/E7 Oncoproteins of High-Risk HPV. J Oncol 2010,2010(530130):10.
19.
go back to reference Al Moustafa AE, Yasmeen A, Achkhar A: Src inhibitors are promising therapy molecules for human cervical carcinomas. Med Hypotheses 2011, 77: 812-814. 10.1016/j.mehy.2011.07.043PubMedCrossRef Al Moustafa AE, Yasmeen A, Achkhar A: Src inhibitors are promising therapy molecules for human cervical carcinomas. Med Hypotheses 2011, 77: 812-814. 10.1016/j.mehy.2011.07.043PubMedCrossRef
20.
go back to reference Faridi R, Zahra A, Khan K, Idrees M: Oncogenic potential of human papillomavirus (HPV) and its relation with cervical cancer. Virol J 2011, 8: 269. 10.1186/1743-422X-8-269PubMedPubMedCentralCrossRef Faridi R, Zahra A, Khan K, Idrees M: Oncogenic potential of human papillomavirus (HPV) and its relation with cervical cancer. Virol J 2011, 8: 269. 10.1186/1743-422X-8-269PubMedPubMedCentralCrossRef
21.
go back to reference Munger K, Howley PM: Human papillomavirus immortalization and transformation functions. Virus Res 2002, 89: 213-228. 10.1016/S0168-1702(02)00190-9PubMedCrossRef Munger K, Howley PM: Human papillomavirus immortalization and transformation functions. Virus Res 2002, 89: 213-228. 10.1016/S0168-1702(02)00190-9PubMedCrossRef
22.
go back to reference Kajitani N, Satsuka A, Kawate A, Sakai H: Productive lifecycle of human papillomaviruses that depends upon squamous epithelial differentiation. Front Microbiol 2012, 3: 152.PubMedPubMedCentralCrossRef Kajitani N, Satsuka A, Kawate A, Sakai H: Productive lifecycle of human papillomaviruses that depends upon squamous epithelial differentiation. Front Microbiol 2012, 3: 152.PubMedPubMedCentralCrossRef
23.
go back to reference Korzeniewski N, Spardy N, Duensing A, Duensing S: Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Lett 2011, 305: 113-122. 10.1016/j.canlet.2010.10.013PubMedPubMedCentralCrossRef Korzeniewski N, Spardy N, Duensing A, Duensing S: Genomic instability and cancer: lessons learned from human papillomaviruses. Cancer Lett 2011, 305: 113-122. 10.1016/j.canlet.2010.10.013PubMedPubMedCentralCrossRef
24.
go back to reference Cardeal LBD, Boccardo E, Termini L, Rabachini T, Andreoli MA, di Loreto C: HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis. PLoS One 2012, 7: e33585. 10.1371/journal.pone.0033585PubMedPubMedCentralCrossRef Cardeal LBD, Boccardo E, Termini L, Rabachini T, Andreoli MA, di Loreto C: HPV16 Oncoproteins Induce MMPs/RECK-TIMP-2 Imbalance in Primary Keratinocytes: Possible Implications in Cervical Carcinogenesis. PLoS One 2012, 7: e33585. 10.1371/journal.pone.0033585PubMedPubMedCentralCrossRef
25.
go back to reference Moody CA, Laimins LA: Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010, 10: 550-560. 10.1038/nrc2886PubMedCrossRef Moody CA, Laimins LA: Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010, 10: 550-560. 10.1038/nrc2886PubMedCrossRef
26.
go back to reference Gyongyosi E, Szalmas A, Ferenczi A, Konya J, Gergely L, Veress G: Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes. Virol J 2012, 9: 36. 10.1186/1743-422X-9-36PubMedPubMedCentralCrossRef Gyongyosi E, Szalmas A, Ferenczi A, Konya J, Gergely L, Veress G: Effects of human papillomavirus (HPV) type 16 oncoproteins on the expression of involucrin in human keratinocytes. Virol J 2012, 9: 36. 10.1186/1743-422X-9-36PubMedPubMedCentralCrossRef
27.
go back to reference Sancier F, Dumont A, Sirvent A, de Plater LP, Edmonds T, David G: Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells. PLoS One 2011, 6: e17237. 10.1371/journal.pone.0017237PubMedPubMedCentralCrossRef Sancier F, Dumont A, Sirvent A, de Plater LP, Edmonds T, David G: Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells. PLoS One 2011, 6: e17237. 10.1371/journal.pone.0017237PubMedPubMedCentralCrossRef
28.
go back to reference Cheng S, Schmidtgrimminger DC, Murant T, Broker TR, Chow LT: Differentiation-dependent Up-regulation of the human papillomavirus E7 gene reactivates cellular Dna-replication in suprabasal differentiated keratinocytes. Genes Dev 1995, 9: 2335-2349. 10.1101/gad.9.19.2335PubMedCrossRef Cheng S, Schmidtgrimminger DC, Murant T, Broker TR, Chow LT: Differentiation-dependent Up-regulation of the human papillomavirus E7 gene reactivates cellular Dna-replication in suprabasal differentiated keratinocytes. Genes Dev 1995, 9: 2335-2349. 10.1101/gad.9.19.2335PubMedCrossRef
29.
go back to reference Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF: Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 2009, 5: e1000318. 10.1371/journal.ppat.1000318PubMedPubMedCentralCrossRef Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF: Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 2009, 5: e1000318. 10.1371/journal.ppat.1000318PubMedPubMedCentralCrossRef
30.
go back to reference Contreras-Paredes A, Cruz-Hernandez E, Martinez-Ramirez I, Duenas-Gonzalez A, Lizano M: E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway. Virology 2009, 383: 78-85. 10.1016/j.virol.2008.09.040PubMedCrossRef Contreras-Paredes A, Cruz-Hernandez E, Martinez-Ramirez I, Duenas-Gonzalez A, Lizano M: E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway. Virology 2009, 383: 78-85. 10.1016/j.virol.2008.09.040PubMedCrossRef
31.
go back to reference Mantovani F, Banks L: The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 2001, 20: 7874-7887. 10.1038/sj.onc.1204869PubMedCrossRef Mantovani F, Banks L: The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 2001, 20: 7874-7887. 10.1038/sj.onc.1204869PubMedCrossRef
32.
go back to reference Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M: Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001, 20: 7888-7898. 10.1038/sj.onc.1204860PubMedCrossRef Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M: Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001, 20: 7888-7898. 10.1038/sj.onc.1204860PubMedCrossRef
33.
go back to reference Baldwin A, Li WL, Grace M, Pearlberg J, Harlow E, Munger K: Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. Proc Natl Acad Sci USA 2008, 105: 16478-16483. 10.1073/pnas.0806195105PubMedPubMedCentralCrossRef Baldwin A, Li WL, Grace M, Pearlberg J, Harlow E, Munger K: Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. Proc Natl Acad Sci USA 2008, 105: 16478-16483. 10.1073/pnas.0806195105PubMedPubMedCentralCrossRef
34.
go back to reference Arulanandam R, Geletu M, Raptis L: The simian virus 40 large tumor antigen activates cSrc and requires cSrc for full neoplastic transformation. Anticancer Res 2010, 30: 47-53.PubMed Arulanandam R, Geletu M, Raptis L: The simian virus 40 large tumor antigen activates cSrc and requires cSrc for full neoplastic transformation. Anticancer Res 2010, 30: 47-53.PubMed
35.
go back to reference Dellas A, Schultheiss E, Almendral AC, Torhorst J, Gudat F: Assessment of EGFR and TGF-alpha expression in relationship to HPV status and KI-67 distribution in cervical intraepithelial neoplasms. Int J Cancer 1996, 69: 165-169. 10.1002/(SICI)1097-0215(19960621)69:3<165::AID-IJC2>3.0.CO;2-YPubMedCrossRef Dellas A, Schultheiss E, Almendral AC, Torhorst J, Gudat F: Assessment of EGFR and TGF-alpha expression in relationship to HPV status and KI-67 distribution in cervical intraepithelial neoplasms. Int J Cancer 1996, 69: 165-169. 10.1002/(SICI)1097-0215(19960621)69:3<165::AID-IJC2>3.0.CO;2-YPubMedCrossRef
36.
go back to reference McCormack SJ, Brazinski SE, Moore JL, Werness BA, Goldstein DJ: Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene 1997, 15: 265-274. 10.1038/sj.onc.1201186PubMedCrossRef McCormack SJ, Brazinski SE, Moore JL, Werness BA, Goldstein DJ: Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene 1997, 15: 265-274. 10.1038/sj.onc.1201186PubMedCrossRef
37.
go back to reference Kasai A, Shima T, Okada M: Role of Src family tyrosine kinases in the down-regulation of epidermal growth factor signaling in PC12 cells. Genes Cells 2005, 10: 1175-1187. 10.1111/j.1365-2443.2005.00909.xPubMedCrossRef Kasai A, Shima T, Okada M: Role of Src family tyrosine kinases in the down-regulation of epidermal growth factor signaling in PC12 cells. Genes Cells 2005, 10: 1175-1187. 10.1111/j.1365-2443.2005.00909.xPubMedCrossRef
38.
go back to reference Thelemann A, Petti F, Griffin G, Iwata K, Hunt T, Settinari T: Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells. Mol Cell Proteomics 2005, 4: 356-376. 10.1074/mcp.M400118-MCP200PubMedCrossRef Thelemann A, Petti F, Griffin G, Iwata K, Hunt T, Settinari T: Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells. Mol Cell Proteomics 2005, 4: 356-376. 10.1074/mcp.M400118-MCP200PubMedCrossRef
39.
go back to reference Weis S, Cui JH, Cheresh D: Unexpected role for VEGF-mediated vascular permeability in tumor cell extravasation and metastasis. J Histochem Cytochem 2004, 52: S12. Weis S, Cui JH, Cheresh D: Unexpected role for VEGF-mediated vascular permeability in tumor cell extravasation and metastasis. J Histochem Cytochem 2004, 52: S12.
40.
go back to reference Zhao J, Guan JL: Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 2009, 28: 35-49. 10.1007/s10555-008-9165-4PubMedCrossRef Zhao J, Guan JL: Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 2009, 28: 35-49. 10.1007/s10555-008-9165-4PubMedCrossRef
Metadata
Title
Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein
Authors
Anita Szalmás
Eszter Gyöngyösi
Annamária Ferenczi
Brigitta László
Tamás Karosi
Péter Csomor
Lajos Gergely
György Veress
József Kónya
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2013
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-10-79

Other articles of this Issue 1/2013

Virology Journal 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine